>>> After Hours Summary: RETA +36% on omaveloxolone data, GLUU

After Hours Summary: RETA +36% on omaveloxolone data, GLUU +8% on S&P SmallCap 600 addition news

After Hours Gainers:

Companies trading higher in after hours in reaction to news: RETA +36.3% (announces that the registrational Part 2 portion of the MOXIe Phase 2 trial of omaveloxolone in patients with Friedreich's ataxia met its primary endpoint), GLUU +8.2% (to join S&P SmallCap 600), SFIX +1.6% (initiated with a Outperform at Robert W. Baird; tgt $28), STT +1.6% (ahead of earnings Oct 18 before the open), WLL +1.4% (Whiting Petroleum considering Abraxas Petroleum [AXAS] acquisition, according to Reuters sources), EHTH +1.3% (initiated with Outperform at Raymond James; tgt $90), RWT +0.8% (to acquire CoreVest American Finance Lender for consideration of ~$490 mln), PD +0.8% (light volume; initiated with Outperform at Robert W. Baird; tgt $31), LDOS +0.7% (awarded TSA screening equipment contract worth ~$926 mln if all options exercised), SQ +0.6% (initiated with a Buy at UBS; tgt $81), WFC +0.5% (ahead of earnings tomorrow before the open)

After Hours Losers:

Companies trading lower in after hours in reaction to news: SEDG -3.1% (will replace International Speedway Corp. [ISCA] in the S&P MidCap 400, Glu Mobile will replace SolarEdge Technologies in the S&P SmallCap 600), BLMN -1.7% (downgraded to Hold from Buy at Deutsche Bank), QIWI -1.4% (announces resignation of CFO Vladislav Poshmorga)